Please login to the form below

Not currently logged in
Email:
Password:

Winner 2010 - Accenture Company of the Year (>£150m)

Winner

Winner: MSD

 

PMEA Winner - Accenture Company Of The Year (>£150 Million)


Criteria

Open to any pharmaceutical, life science or medical device company operating in the UK and/or Europe, this Award goes to a company that can demonstrate outstanding marketing achievement across its entire product range.


Award sponsor


Accenture logo "Accenture seeks to understand and deliver high performance so the Company of the Year Award was a natural choice. This is the pinnacle award that celebrates marketing excellence recognising innovative strategies, highly collaborative teams, leading edge processes and outstanding results."
Patricia Tomasiewicz, life sciences marketing transformation lead, Accenture

 

Company overview

The merger of Merck Sharp & Dohme (MSD) with Schering Plough in 2009 brought together two leading and successful companies. With clearly defined core values and standards, their rigorous approach to marketing science, combined with creative flair, integrity and their use of innovative technologies pushes boundaries in the industry. The success of Remicade speaks volumes for their business acumen, yet running parallel to their commercial and entrepreneurial vision, they have sought out and supported initiatives that foster disease education, prevention and treatment, and promote sustainable access to medicines, vaccines and quality health care.

Accenture company of the year

 

Judges' comments

"MSD not only impressed the judges with their double-digit growth in 2009 and their leading-edge marketing, but also for their willingness to learn from each other as the expertise within both companies came together."

"Individually they were highly regarded companies - together they are one of the industry's marketing powerhouses."

    

Other entries


Sponsors